Details of the Drug

General Information of Drug (ID: DMUZDFR)

• Drug Name: WT2725

Indication

Disease Entry	ICD 11	Status	REF
Haematological malignancy	2B33.Y	Phase 1	[1]
Solid tumour/cancer	2A00-2F9Z	Phase 1	[2]

• Cross-matching ID: TTD ID: D07OTW
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] ClinicalTrials.gov (NCT01621542) Clinical Study of WT2725 in Patients With Advanced Malignancies. U.S. National Institutes of Health.